+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics Contract Development Market by Service Type (Clinical Manufacturing, Commercial Manufacturing, Fill Finish), Molecule Type (Cell Gene Therapy, Monoclonal Antibodies, Recombinant Proteins), Therapeutic Area, Host System, End User, Technology - Global Forecast 2025-2030- Product Image
Biologics Contract Development Market by Service Type (Clinical Manufacturing, Commercial Manufacturing, Fill Finish), Molecule Type (Cell Gene Therapy, Monoclonal Antibodies, Recombinant Proteins), Therapeutic Area, Host System, End User, Technology - Global Forecast 2025-2030- Product Image
Sale

Biologics Contract Development Market by Service Type (Clinical Manufacturing, Commercial Manufacturing, Fill Finish), Molecule Type (Cell Gene Therapy, Monoclonal Antibodies, Recombinant Proteins), Therapeutic Area, Host System, End User, Technology - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011399
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biologics contract development plays a critical role in advancing complex therapeutics through design, optimization, and scalable production. As biopharmaceutical innovation accelerates, organizations turn to expert partners to streamline workflows, overcome technical hurdles, and keep pace with evolving regulatory requirements.

Market Snapshot: Biologics Contract Development Market Size & Growth

The Biologics Contract Development Market grew from USD 7.30 billion in 2024 to USD 8.17 billion in 2025. It is expected to continue growing at a CAGR of 11.85%, reaching USD 14.30 billion by 2030. Increasing demand for personalized therapies, rapid adoption of modular production platforms, and advances in molecular engineering drive this market’s expansion across global supply networks. Supply chain strategies and regulatory frameworks continue to shape the competitive environment for contract development organizations.

Scope & Segmentation of the Biologics Contract Development Market

This report analyzes critical foundations and new opportunities across the biologics contract development value chain. Market coverage spans the following segments:

  • Service Types: Clinical manufacturing (Phase I, II, III); commercial manufacturing; fill-finish; process development (upstream and downstream).
  • Molecule Types: Cell gene therapy; monoclonal antibodies (bispecific, conjugated, naked); recombinant proteins; vaccines (bacterial, mRNA, viral).
  • Therapeutic Areas: Autoimmune disorders; cardiovascular; infectious diseases (bacterial, viral); oncology (hematology, solid tumors).
  • Host Systems: Mammalian (CHO cells, NS0 cells); microbial (E. coli); yeast.
  • End Users: Biopharmaceutical companies; contract manufacturing organizations; pharmaceutical companies.
  • Technologies: Continuous manufacturing (perfusion, single pass); single use systems; stainless steel systems.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including United Kingdom, Germany, France, and others); Asia Pacific (including China, India, Japan, Australia, and others).
  • Key Companies: Lonza Group Ltd, Catalent Inc, Thermo Fisher Scientific Inc, Samsung Biologics Co., Ltd, Boehringer Ingelheim International GmbH, WuXi Biologics Ltd, Fujifilm Diosynth Biotechnologies U.S.A., Inc, AGC Biologics A/S, Recipharm AB, Rentschler Biopharma SE.

Key Takeaways for Senior Decision-Makers

  • The biologics contract development landscape is under transformation, driven by process innovation, digital analytics, and an expanding suite of integrated services.
  • Adoption of single use and modular facilities provides operational agility and helps meet accelerated clinical timelines.
  • Regulatory shifts and globalization put robust quality management, cross-border compliance, and rapid technology transfer at the core of strategic planning.
  • Collaboration models are evolving; organizations benefit from partnerships that integrate regulatory consultation, risk-sharing, and manufacturing expertise.
  • Diverse host systems and molecule modalities require advanced process controls and flexible production platforms, enabling tailored solutions for new therapies.
  • Sustainability and resource efficiency are becoming priorities through use of continuous and single pass manufacturing technologies.

Tariff Impact Across Operations and Supply Chains

New United States tariff measures introduced in 2025 have significant implications for procurement, sourcing, and supply chain diversification strategies. Contract development organizations respond by pursuing onshore sourcing, renegotiating supplier agreements, and forming alliances with domestic manufacturers of essential components. Operational planning increasingly incorporates facility expansion in favorable trade zones and flexible commercial arrangements that account for future tariff risk.

Methodology & Data Sources

This study integrates primary research, including interviews with executive leaders and technical experts across organizations, academic centers, and regulatory bodies. Secondary research draws on peer-reviewed publications, regulatory guidelines, and patent databases, triangulated with association reports and white papers to validate findings. An independent expert panel reviews methodologies and conclusions for rigor and relevance.

Why This Report Matters for Biologics Contract Development Stakeholders

  • Strategic insights empower leaders to align investment, technology, and sourcing strategies with global market trends.
  • Comprehensive segmentation and regional analysis deliver actionable guidance on optimizing operational planning, from early-stage development to commercial production.
  • Clear assessment of regulatory, supply chain, and technological drivers helps reduce risk and accelerate product advancement within competitive timeframes.

Conclusion

Biologics contract development is shaped by innovation, operational adaptability, and evolving regional dynamics. Senior leaders equipped with this report’s insights are positioned to make informed strategic decisions and capitalize on growth opportunities in a complex, global market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of single-use bioreactor technology to enhance flexibility and reduce contamination risks in biologics manufacturing
5.2. Expansion of cell and gene therapy manufacturing services through modular CDMO facilities for rapid clinical scale-up
5.3. Implementation of continuous chromatography and perfusion bioprocessing for increased productivity and cost efficiencies in biologics production
5.4. Integration of AI and machine learning in process development for predictive modeling and accelerated biologic candidate selection
5.5. Growth of specialized fill-finish services tailored for mRNA vaccines and gene therapies with stringent cold chain requirements
5.6. Rising collaborations between regional CMOs and biotech firms to navigate complex global biologics regulatory pathways
5.7. Investment in green biomanufacturing initiatives and sustainable practices to reduce environmental impact of biologics production
5.8. Deployment of digital twin technology and real-time analytics for end-to-end biologics supply chain visibility and risk management
5.9. Emergence of biosimilar-focused CDMOs offering advanced glycoengineering services for next-generation therapeutic antibodies
5.10. Integration of blockchain-enabled traceability solutions to ensure transparency and compliance in biologics serum sourcing
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biologics Contract Development Market, by Service Type
8.1. Introduction
8.2. Clinical Manufacturing
8.2.1. Phase I
8.2.2. Phase II
8.2.3. Phase III
8.3. Commercial Manufacturing
8.4. Fill Finish
8.5. Process Development
8.5.1. Downstream Development
8.5.2. Upstream Development
9. Biologics Contract Development Market, by Molecule Type
9.1. Introduction
9.2. Cell Gene Therapy
9.3. Monoclonal Antibodies
9.3.1. Bispecific
9.3.2. Conjugated
9.3.3. Naked
9.4. Recombinant Proteins
9.5. Vaccines
9.5.1. Bacterial
9.5.2. Mrna
9.5.3. Viral
10. Biologics Contract Development Market, by Therapeutic Area
10.1. Introduction
10.2. Autoimmune Disorders
10.3. Cardiovascular
10.4. Infectious Diseases
10.4.1. Bacterial
10.4.2. Viral
10.5. Oncology
10.5.1. Hematology
10.5.2. Solid Tumors
11. Biologics Contract Development Market, by Host System
11.1. Introduction
11.2. Mammalian
11.2.1. Cho Cells
11.2.2. Ns0 Cells
11.3. Microbial
11.3.1. E Coli
11.4. Yeast
12. Biologics Contract Development Market, by End User
12.1. Introduction
12.2. Biopharmaceutical Companies
12.3. Contract Manufacturing Organizations
12.4. Pharmaceutical Companies
13. Biologics Contract Development Market, by Technology
13.1. Introduction
13.2. Continuous Manufacturing
13.2.1. Perfusion
13.2.2. Single Pass
13.3. Single Use Systems
13.4. Stainless Steel Systems
14. Americas Biologics Contract Development Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Biologics Contract Development Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Biologics Contract Development Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Lonza Group Ltd
17.3.2. Catalent, Inc
17.3.3. Thermo Fisher Scientific Inc
17.3.4. Samsung Biologics Co., Ltd
17.3.5. Boehringer Ingelheim International GmbH
17.3.6. WuXi Biologics Ltd
17.3.7. Fujifilm Diosynth Biotechnologies U.S.A., Inc
17.3.8. AGC Biologics A/S
17.3.9. Recipharm AB
17.3.10. Rentschler Biopharma SE
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. BIOLOGICS CONTRACT DEVELOPMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BIOLOGICS CONTRACT DEVELOPMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BIOLOGICS CONTRACT DEVELOPMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. BIOLOGICS CONTRACT DEVELOPMENT MARKET: RESEARCHAI
FIGURE 28. BIOLOGICS CONTRACT DEVELOPMENT MARKET: RESEARCHSTATISTICS
FIGURE 29. BIOLOGICS CONTRACT DEVELOPMENT MARKET: RESEARCHCONTACTS
FIGURE 30. BIOLOGICS CONTRACT DEVELOPMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOLOGICS CONTRACT DEVELOPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COMMERCIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY FILL FINISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY FILL FINISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY DOWNSTREAM DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY UPSTREAM DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL GENE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CELL GENE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BISPECIFIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BISPECIFIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONJUGATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONJUGATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NAKED, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NAKED, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MRNA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MRNA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BACTERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VIRAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CHO CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NS0 CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY NS0 CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY E COLI, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY E COLI, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PERFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PERFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE PASS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE PASS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE USE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SINGLE USE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STAINLESS STEEL SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STAINLESS STEEL SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 185. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 186. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 187. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 188. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 189. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 190. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 191. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 192. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 193. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 194. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 195. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 196. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 197. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 198. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 199. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 200. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 201. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 202. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 203. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2024 (USD MILLION)
TABLE 204. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2025-2030 (USD MILLION)
TABLE 205. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 206. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 207. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2018-2024 (USD MILLION)
TABLE 208. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2025-2030 (USD MILLION)
TABLE 209. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 212. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 213. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 214. CANADA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 215. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 216. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2025-2030 (USD MILLION)
TABLE 235. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 236. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 237. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2018-2024 (USD MILLION)
TABLE 238. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2025-2030 (USD MILLION)
TABLE 239. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 244. MEXICO BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CLINICAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 279. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 280. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY PROCESS DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 281. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 282. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 283. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 284. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 285. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 286. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 287. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 288. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 289. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 290. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 292. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY HOST SYSTEM, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MAMMALIAN, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY MICROBIAL, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA BIOLOGICS CONTRACT DEVELOPMENT MARKET SIZE, BY CONTINUOUS MANUFACTURING, 2018-2024 (USD MILLION)

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biologics Contract Development market report include:
  • Lonza Group Ltd
  • Catalent, Inc
  • Thermo Fisher Scientific Inc
  • Samsung Biologics Co., Ltd
  • Boehringer Ingelheim International GmbH
  • WuXi Biologics Ltd
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc
  • AGC Biologics A/S
  • Recipharm AB
  • Rentschler Biopharma SE

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.3 Billion
Compound Annual Growth Rate11.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biologics Contract Development & Manufacturing Organization Market by Service Type (Drug Product, Drug Substance), Expression System (Mammalian, Microbial), Therapeutic Category, Development Phase, End User - Global Forecast 2025-2030 - Product Image

Biologics Contract Development & Manufacturing Organization Market by Service Type (Drug Product, Drug Substance), Expression System (Mammalian, Microbial), Therapeutic Category, Development Phase, End User - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Biologics Contract Manufacturing Market by Molecule Type, Process Step, Production Scale, Technology Platform, Therapeutic Area, End User, Manufacturing Model - Global Forecast 2025-2030 - Product Image

Biologics Contract Manufacturing Market by Molecule Type, Process Step, Production Scale, Technology Platform, Therapeutic Area, End User, Manufacturing Model - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, Service (Process Development), Drug Type (Biologics, Biosimilars), Type, Scale of Operation, Therapeutic Area, Region, and Segment Forecasts, 2025-2030 - Product Image

Biopharmaceuticals Contract Manufacturing Market Size, Share, & Trend Analysis Report by Source, Service (Process Development), Drug Type (Biologics, Biosimilars), Type, Scale of Operation, Therapeutic Area, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Indication, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Biologics Contract Manufacturing Market Size, Share & Trends Analysis Report By Product, By Indication, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 180 Pages
  • Global
From
Biologics Contract Development - Global Strategic Business Report - Product Image

Biologics Contract Development - Global Strategic Business Report

  • Report
  • 172 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.